The Mitochondrial Research Context
Mitochondria occupy a central position in longevity research, not simply as the cell's ATP production centres but as dynamic organelles with complex signalling roles. Research has established bidirectional communication between mitochondria and the nucleus — retrograde and anterograde signalling — along with mitochondrial roles in reactive oxygen species (ROS) generation and management, and the relationship between mitochondrial function and cellular senescence.
Three compounds supplied by Nova Biolabs — MOTS-C, SS-31, and NAD+ — each address distinct aspects of mitochondrial and cellular longevity biology, approaching the same organelle from fundamentally different mechanistic angles.
MOTS-C: A Mitochondria-Derived Peptide
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino acid peptide encoded within the mitochondrial 12S ribosomal RNA gene — making it one of a class of peptides known as mitochondria-derived peptides (MDPs). This mitochondrial genomic origin is atypical for biologically active peptides, the majority of which are encoded in the nuclear genome.
In laboratory research, MOTS-C is investigated for:
- Its role in AMPK pathway activation and cellular energy sensing
- Effects on mitochondrial biogenesis and function in cell models
- Interactions with metabolic stress signalling pathways
- Age-associated changes in MOTS-C expression in comparative cell studies
MOTS-C's mitochondrial origin and AMPK-linked activity make it a compound of significant interest for research programmes examining the interface between mitochondrial function, cellular energy homeostasis, and ageing.
MOTS-C is notable as one of very few biologically active peptides with a mitochondrial — rather than nuclear — genomic origin, positioning it at a unique interface between mitochondrial biology and intercellular signalling research.
SS-31: Targeting the Inner Mitochondrial Membrane
SS-31 (also known as Elamipretide, MTP-131, or Szeto-Schiller peptide 31) is a tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. Its research profile is distinct from MOTS-C: rather than acting through nuclear signalling pathways, SS-31 is studied for its direct interaction with cardiolipin, a phospholipid uniquely localised to the inner mitochondrial membrane (IMM).
Cardiolipin plays structural and functional roles in the electron transport chain (ETC) and ATP synthase organisation. In laboratory models, SS-31 research examines:
- Cardiolipin binding and its effects on ETC complex stability
- Mitochondrial membrane potential and ROS production in oxidative stress models
- Bioenergetic output in oxidatively stressed cell lines
- Mitochondrial morphology in models of age-associated mitochondrial fragmentation
The direct membrane-level mechanism of SS-31 places it at a different point in the mitochondrial biology chain compared to MOTS-C's upstream signalling activity, making the two compounds complementary tools in research programmes examining mitochondrial health.
NAD+: The Redox Coenzyme in Longevity Research
Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme present in all living cells, functioning as a hydride transfer agent in cellular redox reactions. Beyond its classical metabolic role in the tricarboxylic acid cycle and oxidative phosphorylation, NAD+ is studied as a signalling molecule via its role as a substrate for sirtuin deacylases (SIRT1–7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases.
Research interest in NAD+ within the longevity field stems from evidence of declining NAD+ pools with cellular ageing and the role of sirtuins as NAD+-dependent regulators of gene expression, DNA repair, and mitochondrial biogenesis. Laboratory research examines:
- NAD+/NADH ratio changes under metabolic stress in cell models
- SIRT1 and SIRT3 activation in response to NAD+ supplementation in cell preparations
- PARP activity and NAD+ consumption in DNA damage response assays
- Effects on mitochondrial function in aged or oxidatively challenged cell preparations
Three Compounds, Complementary Mechanisms
Studying MOTS-C, SS-31, and NAD+ in combination allows researchers to probe mitochondrial biology from multiple levels simultaneously:
| Compound | Primary Mechanism | Level of Action |
|---|---|---|
| MOTS-C | AMPK pathway activation; nuclear gene expression via mitochondrial-derived signalling | Upstream signalling / nuclear |
| SS-31 | Direct cardiolipin interaction at the inner mitochondrial membrane; ETC complex stabilisation | Inner mitochondrial membrane |
| NAD+ | Sirtuin substrate; PARP substrate; redox coenzyme in oxidative phosphorylation | Enzymatic / metabolic |
This complementarity makes the three compounds a natural grouping for research programmes examining mitochondrial health, cellular resilience, and the molecular biology of ageing. Each operates at a distinct level of the mitochondrial biology hierarchy, allowing researchers to dissect which aspects of mitochondrial function are most relevant to their models of interest.
Available from Nova Biolabs
All three compounds are held in UK domestic stock, supplied in lyophilised form for in vitro laboratory research use only:
- MOTS-C — 10mg vial | £30
- SS-31 (Elamipretide) — 10mg vial | £35
- NAD+ — 500mg vial | £40